Improved survival using intensity‐modulated radiation therapy in head and neck cancers: A SEER‐Medicare analysis
Open Access
Abstract
BACKGROUND: Intensity‐modulated radiation therapy (IMRT) is a technologically advanced, and more expensive, method of delivering radiation therapy with a goal of minimizing toxicity. It has been widely adopted for head and neck cancers; however, its comparative impact on cancer control and survival remains unknown. The goal of this analysis was to compare the cause‐specific survival (CSS) for patients with head and neck cancers treated with IMRT versus non‐IMRT from 1999 to 2007.METHODS: CSS was determined using the Surveillance, Epidemiology, and End Results (SEER)‐Medicare database and analyzed regarding treatment details, including the use of IMRT versus non‐IMRT, using claims data. Hazard ratios (HRs) were estimated by the frailty model with a propensity score matching cohort and instrumental variable analysis.RESULTS: A total of 3172 patients were identified. With a median follow‐up of 40 months, patients treated with IMRT had a statistically significant improvement in CSS compared with those treated with non‐IMRT (84.1% versus 66.0%; P < .001). When each anatomic subsite was analyzed separately, all respective subgroups of patients treated with IMRT had better CSS than those treated with non‐IMRT. In multivariable survival analyses, patients treated with IMRT were associated with better CSS (HR = 0.72, 95% confidence interval = 0.59 to 0.90 for propensity score matching; HR = 0.60, 95% confidence interval = 0.41 to 0.88 for instrumental variable analysis).CONCLUSIONS: Patients with head and neck cancers who were treated with IMRT experienced significant improvements in CSS compared with patients treated with non‐IMRT techniques. This suggests there may be benefits to IMRT in cancer outcomes, in addition to toxicity reduction, for this patient population. Cancer 2014;120:702–710. © 2013 American Cancer Society.Keywords
This publication has 33 references indexed in Scilit:
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Intensity-modulated radiotherapy versus conventional and 3D conformal radiotherapy in patients with head and neck cancer: Is there a worthwhile quality of life gain?Cancer Treatment Reviews, 2011
- Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trialThe Lancet Oncology, 2011
- Comparative Effectiveness of Prostate Cancer Treatments: Evaluating Statistical Adjustments for Confounding in Observational DataJNCI: Journal of the National Cancer Institute, 2010
- Evaluation of trends in the use of intensity‐modulated radiotherapy for head and neck cancer from 2000 through 2005Cancer, 2010
- Multi-Institutional Trial of Accelerated Hypofractionated Intensity-Modulated Radiation Therapy for Early-Stage Oropharyngeal Cancer (RTOG 00-22)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Risk Factors and Dose–Effect Relationship for Mandibular Osteoradionecrosis in Oral and Oropharyngeal Cancer PatientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modelingJournal of Health Economics, 2008
- Prospective Randomized Study of Intensity-Modulated Radiotherapy on Salivary Gland Function in Early-Stage Nasopharyngeal Carcinoma PatientsJournal of Clinical Oncology, 2007
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987